524494:BOM
IPCA Laboratories Ltd
1 914,60 INR
arrow_downward
-0,30%(-5,80) 1D
14. 10., 15:30:00 GMT+5:30 · INR
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro 524494…
Otevřít
1 892,95 INR
Max.
1 927,55 INR
Min.
1 864,10 INR
Trž. kap.
484,85 mld.
Prům. obj.
28,74 tis.
Objem
8,52 tis.
Dividenda
0,31 %
Čtvrtletní dividenda
1,50 INR
Datum ex dividenda
7. 8. 2026
Ukazatel P/E
37,08
52týd. max.
2 039,30 INR
52týd. min.
1 252,95 INR
EPS
51,63 INR
Akcie v oběhu
126,35 mil.
Počet zaměstnanců
17 tis.
Otevřít
1 892,95 INR
Max.
1 927,55 INR
Min.
1 864,10 INR
Trž. kap.
484,85 mld.
Prům. obj.
28,74 tis.
Objem
8,52 tis.
Dividenda
0,31 %
Čtvrtletní dividenda
1,50 INR
Datum ex dividenda
7. 8. 2026
Ukazatel P/E
37,08
52týd. max.
2 039,30 INR
52týd. min.
1 252,95 INR
EPS
51,63 INR
Akcie v oběhu
126,35 mil.
Počet zaměstnanců
17 tis.
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
The Daily News | Texas' Oldest Newspaper
·
před 31 minutami
Federal Reserve Chair Jerome Powell interest rate announcement at the New York Stock Exchange (NYSE) in New York City
24/7 Wall St.
·
před 2 hodinami
Michael Burry Says Stocks Could Peak Within 9 Months — and He’s Betting Against the Nasdaq and Chip Stocks
ChartMill
·
před 27 minutami
Most active S&P500 stocks in Wednesday's session
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Informace o IPCA Laboratories Ltd